FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andreas Scorilas

Research Profile

Chemicals & Drugs

Physiology

Gene Expression Regulation, Neoplastic

Procedures

Disorders

Concepts & Ideas

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Kleita Michaelidou; Ioannis Missitzis; Alexandros Ardavanis; Alexandros Tzovaras; Andreas Scorilas
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression.
Marina Devetzi; Andreas Scorilas; Theoni Trangas; Dimitris Xynopoulos; Maroulio Talieri
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
Zsuzsanna Lichner; Lora Rotstein; Andreas Scorilas; Nicole M A White; Kimberly C Wiegand; Christina Chow; Andrew H Girgis; David Huntsman; Ashraf Latif; George M Yousef
The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andreas Scorilas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kleita Michaelidou; Ioannis Missitzis; Alexandros Ardavanis; Alexandros Tzovaras; Andreas Scorilas
The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression.
International journal of oncology 2013;42(5):1770-7.
2013: Marina Devetzi; Andreas Scorilas; Theoni Trangas; Dimitris Xynopoulos; Maroulio Talieri
Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.
Thrombosis and haemostasis 2013;109(4):716-25.
2013: Zsuzsanna Lichner; Lora Rotstein; Andreas Scorilas; Nicole M A White; Kimberly C Wiegand; Christina Chow; Andrew H Girgis; David Huntsman; Ashraf Latif; George M Yousef
The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma.
The American journal of pathology 2013;182(4):1163-70.
2013: Dimitrios Korbakis; Emmanuel G Fragoulis; Andreas Scorilas
Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances.
Anti-cancer drugs 2013;24(3):291-9.
2013: Teodora Karan-Djurasevic; Vuk Palibrk; Sonja Pavlovic; Andreas Scorilas; Vesna Spasovski; Milica Colovic; Natasa Colovic; Irena Glumac; Vladimir Jurisic; Branka Zukic; Natasa Tosic
Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers.
Medical oncology (Northwood, London, England) 2013;30(1):405.
2013: Christos K. Kontos; Iordanis N Papadopoulos; Dimitrios Chantzis; Andreas Scorilas
Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients.
Cancer letters 2013;330(1):106-12.
2013: Georgia Papachristopoulou; Maroulio Talieri; Andreas Scorilas
Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013;34(1):369-78.
2013: Dimitra Florou; Emmanuel G Fragoulis; Iordanis N Papadopoulos; Andreas Scorilas
L-Dopa decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas.
Journal of cancer research and clinical oncology 2013;139(2):297-306.
2013: Panagiota-Aikaterini Geomela; Christos K. Kontos; Ioannis Yiotakis; Andreas Scorilas
Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2013;42(2):154-61.
2013: Konstantinos Mavridis; Konstantinos Stravodimos; Andreas Scorilas
Downregulation and prognostic performance of microRNA 224 expression in prostate cancer.
Clinical chemistry 2013;59(1):261-9.
2012: Dimitra Florou; Konstantinos Mavridis; Andreas Scorilas
The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(6):2069-78.
2012: Christos K Kontos; Andreas Scorilas
Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2012;50(11):1877-91.
2012: Hellinida Thomadaki; Natasa Tosic; Milica Colovic; Kostas V Floros; Dimitrios Gourgiotis; Sonja Pavlovic; Andreas Scorilas
Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
Clinical biochemistry 2012;45(16-17):1362-7.
2012: Eirini Thanopoulou; Nicholaos Ziras; Elizabeth Johnson; Athanassios Kotsinas; George Kotzamanis; Theodoros Mariolis-Sapsakos; Alexandros L Papalambros; Ioannis S Pateras; Andreas Scorilas; Fragiska Sigala; Vassilis G Gorgoulis
The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(5):1429-36.
2012: Maroulio Talieri; Marita Zoma; Marina Devetzi; Andreas Scorilas; Alexandros Ardavanis
Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(5):1375-83.
2012: Georgios Koutalellis; Andreas Lazaris; Konstantinos Mavridis; Andreas Scorilas; Konstantinos Stravodimos; Margaritis Avgeris; Constantinos Constantinides
L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.
BJU international 2012;110(6 Pt B):E267-73.
2012: Christos K. Kontos; Andreas Scorilas
Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family, and their expression analysis in cancer cells.
Gene 2012;505(1):153-66.
2012: Christos Patsis; Emmanuel G Fragoulis; Vasiliki Glyka; Ioannis Yiotakis; Andreas Scorilas
l-DOPA Decarboxylase (DDC) Expression Status as a Novel Molecular Tumor Marker for Diagnostic and Prognostic Purposes in Laryngeal Cancer.
Translational oncology 2012;5(4):288-96.
2012: Constantina D Petraki; Andreas Scorilas; Catherine Streutker; Eleftherios P Diamandis; William Dubinski; Bishoy Khalil; Vassilios Komborozos; Zsuzsanna Lichner; Maria D Pasic; Youssef M Youssef; George M Yousef
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(4):1209-14.
2012: Maroulio Talieri; Nikolaos Tsapralis; Marina Devetzi; Ioannis Missitzis; Eleana Pappa; Andreas Scorilas; Alexandros Ardavanis
Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(4):1075-84.
2012: Hala Faragalla; Michael A S Jewett; Bishoy Khalil; Heba Khella; Zsuzsanna Lichner; Mejia-Guerrero Salvador; Andreas Scorilas; Linda Sugar; Nicole M A White; Magdy I Attalah; Georg Bjarnason; Andrew Evans; Youssef M Youssef; George M Yousef
The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
The Journal of molecular diagnostics : JMD 2012;14(4):385-92.
2012: Ioulia Evangelou; Vassilios Koborozos; Pavlos Msaouel; Georgia Padazi; Constantina Petraki; Andreas Scorilas; Eleni Sdrolia; Michael Koutsilieris
Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer.
European journal of clinical investigation 2012;42(7):777-83.
2012: William Dubinski; Hala Faragalla; Manal Gabril; Andrew H F Girgis; Vladimir V Iakovlev; Kalman Kovacs; Shereen Metias; Anna Plotkin; Fabio Rotondo; Andreas Scorilas; Catherine J Streutker; Androu Arsanious; Youssef M Youssef; George M Yousef
Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
Human pathology 2012;43(7):1037-43.
2012: Christos Patsis; Ioannis Yiotakis; Andreas Scorilas
Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer.
Clinical biochemistry 2012;45(9):623-30.
2012: Dimitrios Korbakis; Andreas Scorilas
Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012;33(3):865-75.
2012: Margaritis Avgeris; Konstantinos Mavridis; Andreas Scorilas
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.
Biological chemistry 2012;393(5):301-17.
2012: Andreas Scorilas; Viktor Magdolen; Konstantinos Mavridis; Hans Fritz
Highlight: the 4th International Symposium on Kallikreins and Kallikrein-related peptidases.
Biological chemistry 2012;393(5):299-300.
2012: Andreas Scorilas; Konstantinos Mavridis
Kallikrein-related peptidases (KLKs) as novel potential biomarkers in gastric cancer: an open yet challenging road lies ahead.
Journal of surgical oncology 2012;105(3):223-4.
2012: Constantina D Petraki; Carol Saleh; Andreas Scorilas; Catherine Streutker; Eleftherios P Diamandis; William Dubinski; Manal Y Gabril; Bishoy Khalil; Vassilios Komborozos; Maria D Pasic; George M Yousef
Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
Pathology, research and practice 2012;208(2):104-8.
2012: Panagiota-Aikaterini Geomela; Christos K. Kontos; Emmanuel G Fragoulis; Ioannis Yiotakis; Andreas Scorilas
L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study.
BMC cancer 2012;12():484.
2012: Flora Tzifi; Alexandros Ardavanis; Christina Economopoulou; Dimitrios Gourgiotis; Sotirios Papageorgiou; Andreas Scorilas
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias.
Advances in hematology 2012;2012():524308.
2011: Margaritis Avgeris; Konstantinos Stravodimos; Andreas Scorilas
Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
The Prostate 2011;71(16):1780-9.
2011: Maroulio Talieri; Panagiotis Prezas; Andreas Scorilas; Aikaterini Apostolaki; Alexandros Ardavanis; Marina Devetzi; Andreas Karameris
Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expression.
Anticancer research 2011;31(9):3093-100.
2011: Maroulio Talieri; Dimitra K Alexopoulou; Niki Arnogiannaki; Marina Devetzi; Dimitrios Kypraios; Matina Patsavela; Andreas Scorilas; Dimitris Xynopoulos
Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(4):737-44.
2011: Konstantina Mathioudaki; Andreas Scorilas; Alexandros Ardavanis; Peggy Lymberi; Evangelos Tsiambas; Marina Devetzi; Aikaterini Apostolaki; Maroulio Talieri
Clinical evaluation of PRMT1 gene expression in breast cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2011;32(3):575-82.
2011: Dimitrios Xinopoulos; Stefanos P Bassioukas; Dimitrios Kypraios; Dimitrios Korkolis; Andreas Scorilas; Konstantinos Mavridis; Dimitrios Dimitroulopoulos; Emmanouil Paraskevas
Pancreatic duct guidewire placement for biliary cannulation in a single-session therapeutic ERCP.
World journal of gastroenterology : WJG 2011;17(15):1989-95.
2011: Julia Dorn; Nadia Harbeck; Ronald Kates; A Gkazepis; Andreas Scorilas; A Soosaipillai; Eleftherios P Diamandis; Marion Kiechle; Barbara Schmalfeldt; Manfred Schmitt
Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(4):877-83.
2011: Ali Fendri; Christos K. Kontos; Abdelmajid Khabir; Raja Mokdad-Gargouri; Andreas Scorilas
BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.
Molecular medicine (Cambridge, Mass.) 2011;17(3-4):163-71.
2011: Dimitrios Xinopoulos; Dimitrios Kypraios; Stefanos P Bassioukas; Dimitrios Korkolis; Konstantinos Mavridis; Andreas Scorilas; Dimitrios Dimitroulopoulos; Argyro Loukou; Emmanouel Paraskevas
Comparative study of balloon and metal olive dilators for endoscopic management of benign anastomotic rectal strictures: clinical and cost-effectiveness outcomes.
Surgical endoscopy 2011;25(3):756-63.
2011: Hellinida Thomadaki; Alexandra Lymberopoulou-Karaliota; Adamantia Maniatakou; Andreas Scorilas
Synthesis, spectroscopic study and anticancer activity of a water-soluble Nb(V) peroxo complex.
Journal of inorganic biochemistry 2011;105(2):155-63.
2011: Margaritis Avgeris; Georgia Papachristopoulou; Athanasios Polychronis; Andreas Scorilas
Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions.
Clinical proteomics 2011;8(1):5.
2011: Sotirios G Papageorgiou; Vassiliki Pappa; Hellinida Thomadaki; John Dervenoulas; Theofanis Economopoulos; Christos K. Kontos; Frieda Kontsioti; Efstathios Papageorgiou; Andreas Scorilas
The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.
The oncologist 2011;16(9):1280-91.
2011: T Jamaspishvili; Andreas Scorilas; M Kral; I Khomeriki; D Kurfurstova; Z Kolar; Jan Bouchal
Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients.
Neoplasma 2011;58(4):298-303.
2011: Georgia Papachristopoulou; Margaritis Avgeris; Antonios Charlaftis; Andreas Scorilas
Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues.
Thrombosis and haemostasis 2011;105(1):131-7.
2010: George Konstantoudakis; Dimitra Florou; Konstantinos Mavridis; Iordanis Papadopoulos; Andreas Scorilas
Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas.
Clinical biochemistry 2010;43(15):1205-11.
2010: Ali Fendri; Christos K. Kontos; Abdelmajid Khabir; Raja Mokdad-Gargouri; Alexandros Ardavanis; Andreas Scorilas
Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2010;31(5):391-9.
2010: Margaritis Avgeris; Konstantinos Mavridis; Andreas Scorilas
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Biological chemistry 2010;391(5):505-11.
2010: Christos K. Kontos; Iordanis Papadopoulos; Emmanuel G Fragoulis; Andreas Scorilas
Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.
British journal of cancer 2010;102(9):1384-90.
2010: Konstantinos Mavridis; Maroulio Talieri; Andreas Scorilas
KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.
Biological chemistry 2010;391(4):467-74.
2010: Konstantinos Mavridis; Margaritis Avgeris; Georgios Koutalellis; Konstantinos Stravodimos; Andreas Scorilas
Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Cancer science 2010;101(3):693-9.
2010: Konstantinos Mavridis; Andreas Scorilas
Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.
Future oncology (London, England) 2010;6(2):269-85.
2010: Tsz-Fung F Chow; Marina Mankaruos; Andreas Scorilas; Youssef Youssef; Andrew Girgis; Sarah Mossad; Shereen Metias; Yostina Rofael; R John Honey; Robert Stewart; Kenneth T Pace; George M Yousef
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
The Journal of urology 2010;183(2):743-51.
2010: Dimitra Florou; Iordanis Papadopoulos; Andreas Scorilas
Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.
Biochemical and biophysical research communications 2010;391(1):214-8.
2009: Amanda Psyrri; Sokratis Papageorgiou; Elisavet Liakata; Andreas Scorilas; DEMETRA RONTOGIANNI; Christos K. Kontos; Pinelopi Argyriou; Dimitrios Pectasides; Nikolaos Harhalakis; Vassiliki Pappa; Aggeliki Kolialexi; Christina Economopoulou; Frida Kontsioti; Eirini Maratou; George Dimitriadis; P Economopoulou; Theofanis Economopoulos
Phosphatidylinositol 3'-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5724-32.
2009: Nashmil Emami; Andreas Scorilas; Antoninus Soosaipillai; Tammy Earle; Brendan Mullen; Eleftherios P Diamandis
Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility.
Biological chemistry 2009;390(9):921-9.
2009: Hellinida Thomadaki; Kostas V Floros; Andreas Scorilas
Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Annals of the New York Academy of Sciences 2009;1171():276-83.
2009: K W Michael Siu; Leroi V DeSouza; Andreas Scorilas; Alexander D Romaschin; R John Honey; Robert Stewart; Kenneth Pace; Youssef Youssef; Tsz-fung F Chow; George M Yousef
Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Journal of proteome research 2009;8(8):3797-807.
2009: Elena Theophanous; Constantina D Petraki; Andreas Scorilas; Vassilios Komborozos; George Veloudis; Jozsef Varga; Marta Zarandi; Andrew V Schally; Michael Koutsilieris
The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer.
Molecular medicine (Cambridge, Mass.) 2009;15(7-8):242-7.
2009: Maroulio Talieri; L Li; Y Zheng; D K Alexopoulou; A Soosaipillai; Andreas Scorilas; Dimitris Xynopoulos; Eleftherios P Diamandis
The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.
British journal of cancer 2009;100(10):1659-65.
2009: Dimitrios Korbakis; Alkiviadis Gregorakis; Andreas Scorilas
Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.
Clinical chemistry 2009;55(5):904-13.
2009: Alexandra Papadokostopoulou; Konstantina Mathioudaki; Andreas Scorilas; Dimitrios Xynopoulos; Alexandros Ardavanis; Elias Kouroumalis; Maroulio Talieri
Colon cancer and protein arginine methyltransferase 1 gene expression.
Anticancer research 2009;29(4):1361-6.
2009: Maroulio Talieri; Konstantina Mathioudaki; Panagiotis Prezas; Dimitra K Alexopoulou; Eleftherios P Diamandis; Dimitris Xynopoulos; Alexandros Ardavanis; Niki Arnogiannaki; Andreas Scorilas
Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Thrombosis and haemostasis 2009;101(4):741-7.
2009: Panteleimon Kountourakis; Amanda Psyrri; Andreas Scorilas; Sonia Markakis; Diane Kowalski; Robert L Camp; Eleftherios P Diamandis; Meletios A Dimopoulos
Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
Thrombosis and haemostasis 2009;101(3):541-6.
2009: Marina Devetzi; Andreas Scorilas; Evangelos Tsiambas; Mansoureh Sameni; Stelios Fotiou; Bonnie F Sloane; Maroulio Talieri
Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker.
Gynecologic oncology 2009;112(3):531-6.
2009: Georgia Papachristopoulou; Margaritis Avgeris; Andreas Scorilas
Expression analysis and study of KLK4 in benign and malignant breast tumours.
Thrombosis and haemostasis 2009;101(2):381-7.
2009: Hellinida Thomadaki; Konstantinos Mavridis; Maroulio Talieri; Andreas Scorilas
Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11.
Thrombosis and haemostasis 2009;101(2):373-80.
2009: Dimitrios Korbakis; Andreas Scorilas
Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(2):100-7.
2008: K Mathioudaki; A Papadokostopoulou; Andreas Scorilas; D Xynopoulos; N Agnanti; M Talieri
The PRMT1 gene expression pattern in colon cancer.
British journal of cancer 2008;99(12):2094-9.
2008: Christos K. Kontos; Iordanis N Papadopoulos; Andreas Scorilas
Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Biological chemistry 2008;389(12):1467-75.
2008: Panteleimon Kountourakis; Amanda Psyrri; Andreas Scorilas; Robert L Camp; Sonia Markakis; Diane Kowalski; Eleftherios P Diamandis; Meletios A Dimopoulos
Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA).
Cancer science 2008;99(11):2224-9.
2008: Hellinida Thomadaki; Andreas Scorilas
Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol.
Biological chemistry 2008;389(11):1427-34.
2008: Margaritis Avgeris; Georgios Koutalellis; Emmanuel G Fragoulis; Andreas Scorilas
Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer.
Clinical biochemistry 2008;41(14-15):1140-9.
2008: Hellinida Thomadaki; Alexandra Karaliota; Charalambos Litos; Andreas Scorilas
Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines.
Journal of medicinal chemistry 2008;51(13):3713-9.
2008: A Garoufali; F Kyriakou; Panteleimon Kountourakis; I Yioti; S Malliou; A Nikaki; E Kardara; I Frangos; S Koumna; Nikolaos Baziotis; Andreas Scorilas; Alexandros Ardavanis
Extracellular domain of HER2: a useful marker for the initial workup and follow-up of HER2-positive breast cancer.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2008;13(3):409-13.
2008: Alexandros Ardavanis; Stella Koumna; Ioannis Fragos; Savvoula Malliou; Flora Kyriakou; Ioannis Mantzaris; Andreas Scorilas; Gerasimos Rigatos
Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity.
Anticancer research 2008;28(4C):2409-15.
2008: Amanda Psyrri; P Kountourakis; Andreas Scorilas; Sonia Markakis; Robert L Camp; Diane Kowalski; Eleftherios P Diamandis; Meletios A Dimopoulos
Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1271-7.
2008: Alkibiades K Gregorakis; Stefanos Stefanakis; Dimitrios Malovrouvas; Konstantina Petraki; Dimitrios Gourgiotis; Andreas Scorilas
Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.
The Prostate 2008;68(7):759-65.
2008: Georgios Pampalakis; Andreas Scorilas; Georgia Sotiropoulou
Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer.
Clinical biochemistry 2008;41(7-8):591-7.
2008: Alexandros Ardavanis; Panteleimon Kountourakis; Flora Kyriakou; Savoula Malliou; Ioannis Mantzaris; Anastasia Garoufali; Ioulia Yiotis; Andreas Scorilas; Nikolaos Baziotis; Gerasimos Rigatos
Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer.
The oncologist 2008;13(4):361-9.
2008: Hellinida Thomadaki; Chris Milto Tsiapalis; Andreas Scorilas
The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines.
Cancer chemotherapy and pharmacology 2008;61(4):703-11.
2008: Hellinida Thomadaki; Andreas Scorilas; Chris Milto Tsiapalis; Maria Havredaki
The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner.
Cancer chemotherapy and pharmacology 2008;61(2):251-65.
2008: Hellinida Thomadaki; Andreas Scorilas
Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs.
Connective tissue research 2008;49(3):261-4.
2007: Yingye Zheng; Dionyssios Katsaros; Shannon J C Shan; Irene Rigault de la Longrais; Mauro Porpiglia; Andreas Scorilas; Nam W Kim; Robert L Wolfert; Iris Simon; Lin Li; Ziding Feng; Eleftherios P Diamandis
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(23):6984-92.
2007: Kyriakos Revelos; Constantina D Petraki; Andreas Scorilas; Stefanos Stefanakis; Dimitrios Malovrouvas; Nektarios Alevizopoulos; George Kanellis; Antonis Halapas; Michael Koutsilieris
Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
Anticancer research 2007;27(5B):3651-60.
2007: Maria E Katsarou; Hellinida Thomadaki; Nikos Katsaros; Andreas Scorilas
Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells.
Biological chemistry 2007;388(8):773-8.
2007: Iris Simon; Dionyssios Katsaros; Irene A Rigault de la Longrais; Marco Massobrio; Andreas Scorilas; Nam W Kim; Mark J Sarno; Robert L Wolfert; Eleftherios P Diamandis
B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression.
Gynecologic oncology 2007;106(2):334-41.
2007: Hellinida Thomadaki; Alexandra Karaliota; Charalambos Litos; Andreas Scorilas
Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI), and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines.
Journal of medicinal chemistry 2007;50(6):1316-21.
2007: Julia Dorn; Manfred Schmitt; Ronald Kates; Barbara Schmalfeldt; Marion Kiechle; Andreas Scorilas; Eleftherios P Diamandis; Nadia Harbeck
Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1742-8.
2007: Hellinida Thomadaki; Maroulio Talieri; Andreas Scorilas
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Cancer letters 2007;247(1):48-55.
2007: Shannon J C Shan; Andreas Scorilas; Dionyssios Katsaros; Eleftherios P Diamandis
Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
British journal of cancer 2007;96(2):362-72.
2007: Hellinida Thomadaki; Andreas Scorilas
Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Annals of the New York Academy of Sciences 2007;1095():35-44.
2007: Eleni K Efthimiadou; Hellinida Thomadaki; Yiannis Sanakis; Catherine P Raptopoulou; Nikos Katsaros; Andreas Scorilas; Alexandra Karaliota; George Psomas
Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2'-bipyridine.
Journal of inorganic biochemistry 2007;101(1):64-73.
2006: Kostas V Floros; Hellinida Thomadaki; Dimitra Florou; Maroulio Talieri; Andreas Scorilas
Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
Annals of the New York Academy of Sciences 2006;1090():89-97.
2006: Kostas V Floros; Maroulio Talieri; Andreas Scorilas
Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
Biological chemistry 2006;387(12):1629-33.
2006: Theoni Leoutsakou; Maroulio Talieri; Andreas Scorilas
Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancer.
Biological chemistry 2006;387(12):1613-8.
2006: Panagiotis Prezas; Andreas Scorilas; Christina Yfanti; Petar Viktorov; Niki Agnanti; Eleftherios Diamandis; Maroulio Talieri
The role of human tissue kallikreins 7 and 8 in intracranial malignancies.
Biological chemistry 2006;387(12):1607-12.
2006: Shannon J C Shan; Andreas Scorilas; Dionyssios Katsaros; Irene A Rigault de la Longrais; Marco Massobrio; Eleftherios P Diamandis
Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
Clinical chemistry 2006;52(10):1879-86.
2006: Hellinida Thomadaki; Maroulio Talieri; Andreas Scorilas
Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS.
Biological chemistry 2006;387(8):1081-6.
2006: Margrita H Slagter; Andreas Scorilas; Louis J G Gooren; Willem de Ronde; Antoninus Soosaipillai; Erik J Giltay; Miltiadis Paliouras; Eleftherios P Diamandis
Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.
Clinical chemistry 2006;52(8):1546-51.
2006: Margrita H Slagter; Louis J G Gooren; Andreas Scorilas; Constantina D Petraki; Eleftherios P Diamandis
Effects of long-term androgen administration on breast tissue of female-to-male transsexuals.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2006;54(8):905-10.
2006: Margrita H Slagter; Louis J G Gooren; Willem de Ronde; Antoninus Soosaipillai; Andreas Scorilas; Erik J Giltay; Miltiadis Paliouras; Eleftherios P Diamandis
Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens.
Clinical chemistry 2006;52(7):1356-65.
2006: Theoni Leoutsakou; Maroulio Talieri; Andreas Scorilas
Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
Biochemical and biophysical research communications 2006;344(2):667-74.
2006: Andreas Scorilas; Alkiviadis Gregorakis
mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy.
Biological chemistry 2006;387(6):789-93.
2006: Ake Lundwall; Vimla Band; Michael Blaber; Judith A Clements; Yves Courty; Eleftherios P Diamandis; Hans Fritz; Hans Lilja; Johan Malm; Lois J Maltais; A Yvonne Olsson; Constantina D Petraki; Andreas Scorilas; Georgia Sotiropoulou; Ulf-Hakan Stenman; Carsten Stephan; Maroulio Talieri; George M Yousef
A comprehensive nomenclature for serine proteases with homology to tissue kallikreins.
Biological chemistry 2006;387(6):637-41.
2006: Alexandros Ardavanis; Andreas Scorilas; Dimitrios Tryfonopoulos; George Orphanos; Ioannis Missitzis; Michalis V Karamouzis; Minas Chrysochoou; Anastasia Sotiropoulou; Niki Arnogiannaki; Georgios Ioannidis; Georgios Pissakas; Gerasimos Rigatos
Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine, and Fluorouracil chemotherapy, surgery, and radiotherapy: long-term results.
The oncologist 2006;11(6):563-73.
2006: Carla A Borgoño; Tadaaki Kishi; Andreas Scorilas; Nadia Harbeck; Julia Dorn; Barbara Schmalfeldt; Manfred Schmitt; Eleftherios P Diamandis
Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(5):1487-93.
2006: Katerina Oikonomopoulou; Andreas Scorilas; Iacovos Michael; Linda Grass; Antoninus Soosaipillai; Barry Rosen; Joan Murphy; Eleftherios P Diamandis
Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(2):104-14.
2006: Hellinida Thomadaki; Andreas Scorilas
BCL2 family of apoptosis-related genes: functions and clinical implications in cancer.
Critical reviews in clinical laboratory sciences 2006;43(1):1-67.
2005: Alexandros Ardavanis; Dimitrios Tryfonopoulos; G Orfanos; Michalis V Karamouzis; Andreas Scorilas; Athanasios Alexopoulos; Gerasimos Rigatos
Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: findings from a case series.
Onkologie 2005;28(11):558-64.
2005: Kyriakos Revelos; Constantina D Petraki; Alkiviadis Gregorakis; Andreas Scorilas; Panagiotis Papanastasiou; Roxane Tenta; Michael Koutsilieris
p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
In vivo (Athens, Greece) 2005;19(5):911-20.
2005: Maria E Katsarou; Athanasios Papakyriakou; Nikos Katsaros; Andreas Scorilas
Expression of the C-terminal domain of novel human SR-A1 protein: interaction with the CTD domain of RNA polymerase II.
Biochemical and biophysical research communications 2005;334(1):61-8.
2005: Alkiviadis Gregorakis; Dimitrios Malovrouvas; Stefanos Stefanakis; Konstantina Petraki; Andreas Scorilas
Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):196-201.
2005: Andreas Scorilas; Kalomoira Agiamarnioti; Kyriakos Papadopoulos
Novel biotinylated acridinium derivatives: new reagents for fluorescence immunoassays and proteomics.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):159-67.
2005: Panagiota Stavropoulou; Alkiviadis Gregorakis; Mario Plebani; Andreas Scorilas
Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
Clinica chimica acta; international journal of clinical chemistry 2005;357(2):190-5.
2005: A Yannopoulos; Efthymios Dimitriadis; Andreas Scorilas; Theoni Trangas; Evagelos Markakis; Maroulio Talieri
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete.
British journal of cancer 2005;93(1):152-8.
2005: Kyriakos Revelos; Constantina D Petraki; Alkiviadis Gregorakis; Andreas Scorilas; Panagiotis Papanastasiou; Michael Koutsilieris
Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy.
Anticancer research 2005;25(4):3123-33.
2005: Hellinida Thomadaki; Chris Milto Tsiapalis; Andreas Scorilas
Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction.
Biological chemistry 2005;386(5):471-80.
2005: George M Yousef; Christina V Obiezu; Liu-Ying Luo; Angeliki Magklara; Carla A Borgoño; Tadaaki Kishi; Nader Memari; lacovos P Michael; Michael Sidiropoulos; Lisa Kurlender; Katerina Economopolou; Carl Kapadia; Nahoko Komatsu; Constantina D Petraki; Marc Elliott; Andreas Scorilas; Dionyssios Katsaros; Michael A Levesque; Eleftherios P Diamandis
Human tissue kallikreins: from gene structure to function and clinical applications.
Advances in clinical chemistry 2005;39():11-79.
2004: Kostas V Floros; Hellinida Thomadaki; Nikos Katsaros; Maroulio Talieri; Andreas Scorilas
mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin.
Biological chemistry 2004;385(11):1099-103.
2004: Konstantina Mathioudaki; Theoni Leotsakou; Alexandra Papadokostopoulou; Emmanuel Paraskevas; Alexandros Ardavanis; Maroulio Talieri; Andreas Scorilas
SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression.
Biological chemistry 2004;385(9):785-90.
2004: Konstantina Mathioudaki; Andreas Scorilas; Alexandra Papadokostopoulou; Dimitrios Xynopoulos; Niki Arnogianaki; Niki Agnanti; Maroulio Talieri
Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Biological chemistry 2004;385(9):779-83.
2004: Eleftherios P Diamandis; Carla A Borgoño; Andreas Scorilas; Nadia Harbeck; Julia Dorn; Manfred Schmitt
Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients.
Clinical biochemistry 2004;37(9):823-9.
2004: Maroulio Talieri; Sofia Papadopoulou; Andreas Scorilas; Dimitrios Xynopoulos; Niki Arnogianaki; George Plataniotis; Julia Yotis; Niki Agnanti
Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Cancer letters 2004;205(1):97-106.
2004: Eleftherios P Diamandis; Andreas Scorilas; Tadaaki Kishi; Kaj Blennow; Liu-Ying Luo; Antoninus Soosaipillai; Alfred W Rademaker; Magnus Sjogren
Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Clinical biochemistry 2004;37(3):230-7.
2004: Andreas Scorilas; Carla A Borgoño; Nadia Harbeck; Julia Dorn; Barbara Schmalfeldt; Manfred Schmitt; Eleftherios P Diamandis
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):678-85.
2004: Maroulio Talieri; Eleftherios P Diamandis; Dimitrios Gourgiotis; Konstantina Mathioudaki; Andreas Scorilas
Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.
Thrombosis and haemostasis 2004;91(1):180-6.
2004: Carsten Stephan; George M Yousef; Andreas Scorilas; Klaus Jung; Monika Jung; Glen Kristiansen; Steffen Hauptmann; Tadaaki Kishi; Terukazu Nakamura; Stefan A Loening; Eleftherios P Diamandis
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
The Journal of urology 2004;171(1):187-91.
2003: Kostas V Floros; Hellinida Thomadaki; George Lallas; Nikos Katsaros; Maroulio Talieri; Andreas Scorilas
Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12.
Annals of the New York Academy of Sciences 2003;1010():153-8.
2003: Eleftherios P Diamandis; Carla A Borgoño; Andreas Scorilas; George M Yousef; Nadia Harbeck; Julia Dorn; Barbara Schmalfeldt; Manfred Schmitt
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(6):299-309.
2003: Terukazu Nakamura; Andreas Scorilas; Carsten Stephan; Klaus Jung; Antoninus Soosaipillai; Eleftherios P Diamandis
The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia.
Cancer research 2003;63(19):6543-6.
2003: Carla A Borgoño; Stefano Fracchioli; George M Yousef; Irene A Rigault de la Longrais; Liu-Ying Luo; Antoninus Soosaipillai; Manuela Puopolo; Linda Grass; Andreas Scorilas; Eleftherios P Diamandis; Dionyssios Katsaros
Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
International journal of cancer. Journal international du cancer 2003;106(4):605-10.
2003: George M Yousef; Carsten Stephan; Andreas Scorilas; Mohamed Abd Ellatif; Klaus Jung; Glen Kristiansen; Monika Jung; Mary-Ellen Polymeris; Eleftherios P Diamandis
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
The Prostate 2003;56(4):287-92.
2003: George M Yousef; Andreas Scorilas; Dionyssios Katsaros; Stefano Fracchioli; Lisa Iskander; Carla Borgono; Irene A Rigault de la Longrais; Manuela Puopolo; Marco Massobrio; Eleftherios P Diamandis
Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(16):3119-26.
2003: George M Yousef; Mary-Ellen Polymeris; Linda Grass; Antoninus Soosaipillai; Pak-Cheung Chan; Andreas Scorilas; Carla A Borgoño; Nadia Harbeck; Barbara Schmalfeldt; Julia Dorn; Manfred Schmitt; Eleftherios P Diamandis
Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Cancer research 2003;63(14):3958-65.
2003: Maroulio Talieri; Eleftherios P Diamandis; Nikos Katsaros; Dimitrios Gourgiotis; Andreas Scorilas
Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Thrombosis and haemostasis 2003;89(6):1081-8.
2003: Tadaaki Kishi; Linda Grass; Antoninus Soosaipillai; Andreas Scorilas; Nadia Harbeck; Barbara Schmalfeldt; Julia Dorn; Michal Mysliwiec; Manfred Schmitt; Eleftherios P Diamandis
Human kallikrein 8, a novel biomarker for ovarian carcinoma.
Cancer research 2003;63(11):2771-4.
2003: Andreas Scorilas; Pui Ming Chiang; Dionyssios Katsaros; George M Yousef; Eleftherios P Diamandis
Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors.
Gene 2003;310():79-89.
2003: Terukazu Nakamura; Carsten Stephan; Andreas Scorilas; George M Yousef; Klaus Jung; Eleftherios P Diamandis
Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues.
Urology 2003;61(5):1042-6.
2003: George M Yousef; Mary-Ellen Polymeris; George M Yacoub; Andreas Scorilas; Antoninus Soosaipillai; Cynthia Popalis; Stefano Fracchioli; Dionyssios Katsaros; Eleftherios P Diamandis
Parallel overexpression of seven kallikrein genes in ovarian cancer.
Cancer research 2003;63(9):2223-7.
2003: T Nakamura; Andreas Scorilas; C Stephan; George M Yousef; G Kristiansen; Klaus Jung; Eleftherios P Diamandis
Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues.
British journal of cancer 2003;88(7):1101-4.
2003: Eleftherios P Diamandis; Andreas Scorilas; Stefano Fracchioli; Marleen Van Gramberen; Henk De Bruijn; Alfthan Henrik; Antoninus Soosaipillai; Linda Grass; George M Yousef; Ulf-Hakan Stenman; Marco Massobrio; Ate G J van der Zee; Ignace Vergote; Dionyssios Katsaros
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1035-43.
2003: George M Yousef; Andreas Scorilas; Terukazu Nakamura; Mohamed Abd Ellatif; Riccardo Ponzone; Nicoletta Biglia; Furio Maggiorotto; Riccardo Roagna; Piero Sismondi; Eleftherios P Diamandis
The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer.
Breast cancer research and treatment 2003;78(2):149-58.
2003: George M Yousef; Stefano Fracchioli; Andreas Scorilas; Carla A Borgoño; Lisa Iskander; Manuela Puopolo; Marco Massobrio; Eleftherios P Diamandis; Dionyssios Katsaros
Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer.
American journal of clinical pathology 2003;119(3):346-55.
2003: Lianna G Kyriakopoulou; George M Yousef; Andreas Scorilas; Dionyssios Katsaros; Marco Massobrio; Stefano Fracchioli; Eleftherios P Diamandis
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Clinical biochemistry 2003;36(2):135-43.
2003: Liu-Ying Luo; Dionyssios Katsaros; Andreas Scorilas; Stefano Fracchioli; Roberto Bellino; Marleen van Gramberen; Henk de Bruijn; Alfthan Henrik; Ulf-Hakan Stenman; Marco Massobrio; Ate G J van der Zee; Ignace Vergote; Eleftherios P Diamandis
The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.
Cancer research 2003;63(4):807-11.
2003: Andreas Scorilas; Mario Plebani; Saverio Mazza; Daniela Basso; Antoninus Soosaipillai; Nikos Katsaros; Francesco Pagano; Eleftherios P Diamandis
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
The Prostate 2003;54(3):220-9.
2003: Carsten Stephan; George M Yousef; Andreas Scorilas; Klaus Jung; Monika Jung; Glen Kristiansen; Steffen Hauptmann; Bhupinder S Bharaj; Terukazu Nakamura; Stefan A Loening; Eleftherios P Diamandis
Quantitative analysis of kallikrein 15 gene expression in prostate tissue.
The Journal of urology 2003;169(1):361-4.
2002: George M Yousef; Andreas Scorilas; Angeliki Magklara; Nader Memari; Riccardo Ponzone; Piero Sismondi; Nicoletta Biglia; M Abd Ellatif; Eleftherios P Diamandis
The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
British journal of cancer 2002;87(11):1294-300.
2002: George M Yousef; Carla A Borgoño; Andreas Scorilas; Riccardo Ponzone; Nicoletta Biglia; Lisa Iskander; Mary-Ellen Polymeris; Riccardo Roagna; Piero Sismondi; Eleftherios P Diamandis
Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis.
British journal of cancer 2002;87(11):1287-93.
2002: George M Yousef; Christina V Obiezu; Klaus Jung; Carsten Stephan; Andreas Scorilas; Eleftherios P Diamandis
Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues.
Urology 2002;60(4):714-8.
2002: Barry R Hoffman; Dionyssios Katsaros; Andreas Scorilas; P Diamandis; Stefano Fracchioli; Irene A Rigault de la Longrais; T Colgan; Manuela Puopolo; G Giardina; Marco Massobrio; Eleftherios P Diamandis
Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker.
British journal of cancer 2002;87(7):763-71.
2002: George M Yousef; Andreas Scorilas; Lianna G Kyriakopoulou; Laura Rendl; Maria Diamandis; Riccardo Ponzone; Nicoletta Biglia; Maurizia Giai; Riccardo Roagna; Piero Sismondi; Eleftherios P Diamandis
Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer.
Clinical chemistry 2002;48(8):1241-50.
2002: Christina V Obiezu; Antoninus Soosaipillai; Klaus Jung; Carsten Stephan; Andreas Scorilas; David H C Howarth; Eleftherios P Diamandis
Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry.
Clinical chemistry 2002;48(8):1232-40.
2002: Andreas Scorilas; Stelios Fotiou; Evangelos Tsiambas; Julia Yotis; Fani Kotsiandri; Mansoureh Sameni; Bonnie F Sloane; Maroulio Talieri
Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients.
Biological chemistry 2002;383(7-8):1297-303.
2002: Andreas Scorilas
Polyadenylate polymerase (PAP) and 3' end pre-mRNA processing: function, assays, and association with disease.
Critical reviews in clinical laboratory sciences 2002;39(3):193-224.
2002: Albert Chang; George M Yousef; Andreas Scorilas; Linda Grass; Piero Sismondi; Riccardo Ponzone; Eleftherios P Diamandis
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.
British journal of cancer 2002;86(9):1457-64.
2002: Sofia Papadopoulou; Andreas Scorilas; Julia Yotis; Niki Arnogianaki; George Plataniotis; Niki Agnanti; Maroulio Talieri
Significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 (PAI-1) expression in human colorectal carcinomas.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2002;23(3):170-8.
2002: Maryam Zarghooni; Antoninus Soosaipillai; Linda Grass; Andreas Scorilas; Nader Mirazimi; Eleftherios P Diamandis
Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients.
Clinical biochemistry 2002;35(3):225-31.
2002: Andreas Scorilas; Michael A Levesque; Linda K Ashworth; Eleftherios P Diamandis
Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.
Gene 2002;289(1-2):191-9.
2002: George M Yousef; Andreas Scorilas; Albert Chang; Laura Rendl; Maria Diamandis; Klaus Jung; Eleftherios P Diamandis
Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
The Prostate 2002;51(2):126-32.
2001: Sofia Papadopoulou; Andreas Scorilas; Niki Arnogianaki; B Papapanayiotou; A Tzimogiani; N Agnantis; Maroulio Talieri
Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(6):383-9.
2001: George M Yousef; Lianna G Kyriakopoulou; Andreas Scorilas; Stefano Fracchioli; Bruno Ghiringhello; Maryam Zarghooni; Albert Chang; Maria Diamandis; G Giardina; Warren Hartwick; Giovanni Richiardi; Marco Massobrio; Eleftherios P Diamandis; Dionyssios Katsaros
Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Cancer research 2001;61(21):7811-8.
2001: Christina V Obiezu; Andreas Scorilas; Dionyssios Katsaros; Marco Massobrio; George M Yousef; Stefano Fracchioli; Irene A Rigault de la Longrais; RICCARDO ARISIO; Eleftherios P Diamandis
Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2380-6.
2001: Liu-Ying Luo; Dionyssios Katsaros; Andreas Scorilas; Stefano Fracchioli; R Piccinno; Irene A Rigault de la Longrais; David J C Howarth; Eleftherios P Diamandis
Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2372-9.
2001: Andreas Scorilas; Lianna G Kyriakopoulou; Dionyssios Katsaros; Eleftherios P Diamandis
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
British journal of cancer 2001;85(2):190-8.
2001: Andreas Scorilas; George M Yousef; Klaus Jung; E Rajpert-De Meyts; S Carsten; Eleftherios P Diamandis
Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors.
Biochemical and biophysical research communications 2001;285(2):400-8.
2001: Andreas Scorilas; Andreas Karameris; N Arnogiannaki; Alexandros Ardavanis; P Bassilopoulos; Theoni Trangas; Maroulio Talieri
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients.
British journal of cancer 2001;84(11):1488-96.
2001: Angeliki Magklara; Andreas Scorilas; Dionyssios Katsaros; Marco Massobrio; George M Yousef; Stefano Fracchioli; S Danese; Eleftherios P Diamandis
The human KLK8 (neuropsin/ovasin) gene: identification of two novel splice variants and its prognostic value in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):806-11.
2001: Christina V Obiezu; Andreas Scorilas; Angeliki Magklara; M H Thornton; C Y Wang; F Z Stanczyk; Eleftherios P Diamandis
Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome.
The Journal of clinical endocrinology and metabolism 2001;86(4):1558-61.
2001: Liu-Ying Luo; Peter S Bunting; Andreas Scorilas; Eleftherios P Diamandis
Human kallikrein 10: a novel tumor marker for ovarian carcinoma?
Clinica chimica acta; international journal of clinical chemistry 2001;306(1-2):111-8.
2001: Andreas Scorilas; Bhupinder B Bharaj; Maurizia Giai; Eleftherios P Diamandis
Codon 89 polymorphism in the human 5 alpha-reductase gene in primary breast cancer.
British journal of cancer 2001;84(6):760-7.
2001: H Kim; Andreas Scorilas; Dionyssios Katsaros; George M Yousef; Marco Massobrio; Stefano Fracchioli; R Piccinno; G Gordini; Eleftherios P Diamandis
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
British journal of cancer 2001;84(5):643-50.
2001: Andreas Scorilas; Lianna G Kyriakopoulou; George M Yousef; Linda K Ashworth; A Kwamie; Eleftherios P Diamandis
Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family.
Genomics 2001;72(2):217-21.
2001: Javad Khosravi; Anastasia Diamandi; Jehangir Mistry; Andreas Scorilas
Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer.
The Journal of clinical endocrinology and metabolism 2001;86(2):694-9.
2001: George M Yousef; Andreas Scorilas; Klaus Jung; Linda K Ashworth; Eleftherios P Diamandis
Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.
The Journal of biological chemistry 2001;276(1):53-61.
2001: Ioannis Kalomenidis; Dora Orphanidou; G Papamichalis; T Vassilakopoulos; Andreas Scorilas; A Rasidakis; H Papastamatiou; JB Jordanoglou; Charis Roussos; A Skorilas
Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
Lung 2001;179(5):265-78.
2000: Andreas Scorilas; MH Black; M Talieri; Eleftherios P Diamandis
Genomic organization, physical mapping, and expression analysis of the human protein arginine methyltransferase 1 gene.
Biochemical and biophysical research communications 2000;278(2):349-59.
2000: Andreas Scorilas; Maroulio Talieri; Alexandros Ardavanis; Nelly Courtis; Efthymios Dimitriadis; Julia Yotis; Chris Milto Tsiapalis; Theoni Trangas
Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Cancer research 2000;60(19):5427-33.
2000: George M Yousef; Albert Chang; Andreas Scorilas; Eleftherios P Diamandis
Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4.
Biochemical and biophysical research communications 2000;276(1):125-33.
2000: Andreas Scorilas; A Bjartell; Hans Lilja; C Moller; Eleftherios P Diamandis
Streptavidin-polyvinylamine conjugates labeled with a europium chelate: applications in immunoassay, immunohistochemistry, and microarrays.
Clinical chemistry 2000;46(9):1450-5.
2000: AD Sklavounou; Evanthia Chrysomali; Andreas Scorilas; Andreas Karameris
TNF-alpha expression and apoptosis-regulating proteins in oral lichen planus: a comparative immunohistochemical evaluation.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2000;29(8):370-5.
2000: Angeliki Magklara; Andreas Scorilas; Carsten Stephan; G O Kristiansen; S Hauptmann; Klaus Jung; Eleftherios P Diamandis
Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
Urology 2000;56(3):527-32.
2000: George M Yousef; Andreas Scorilas; Angeliki Magklara; Antoninus Soosaipillai; Eleftherios P Diamandis
The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family - genomic characterization, mapping, tissue expression and hormonal regulation.
Gene 2000;254(1-2):119-28.
2000: Andreas Scorilas; Eleftherios P Diamandis
Polyvinylamine-streptavidin complexes labeled with a europium chelator: a universal detection reagent for solid-phase time resolved fluorometric applications.
Clinical biochemistry 2000;33(5):345-50.
2000: Christina V Obiezu; Erik J Giltay; Angeliki Magklara; Andreas Scorilas; Louis J G Gooren; Hong Yu; David J C Howarth; Eleftherios P Diamandis
Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals.
Clinical chemistry 2000;46(6 Pt 1):859-62.
2000: Bhupinder B Bharaj; Andreas Scorilas; Eleftherios P Diamandis; Maurizia Giai; Michael A Levesque; D J Sutherland; Barry R Hoffman
Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter.
Breast cancer research and treatment 2000;61(2):111-9.
2000: Bhupinder B Bharaj; Andreas Scorilas; Maurizia Giai; Eleftherios P Diamandis
TA repeat polymorphism of the 5alpha-reductase gene and breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(4):387-93.
2000: Robert K Nam; E P Diamandis; Ants Toi; J Trachtenberg; A Magklara; Andreas Scorilas; P A Papnastasiou; Michael A S Jewett; steven narod
Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1036-42.
2000: Christina V Obiezu; Erik J Giltay; Angeliki Magklara; Andreas Scorilas; Louis J G Gooren; Hong Yu; Eleftherios P Diamandis
Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals.
The Journal of urology 2000;163(3):802-5.
2000: Andreas Scorilas; H Yu; Antoninus Soosaipillai; A K Gregorakis; Eleftherios P Diamandis
Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy.
Clinica chimica acta; international journal of clinical chemistry 2000;292(1-2):127-38.
2000: George M Yousef; Andreas Scorilas; Eleftherios P Diamandis
Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family.
Genomics 2000;63(1):88-96.
1999: Andreas Scorilas; Theoni Trangas; Julia Yotis; C Pateras; Maroulio Talieri
Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
British journal of cancer 1999;81(8):1385-91.
1999: Angeliki Magklara; Andreas Scorilas; W J Catalona; Eleftherios P Diamandis
The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA.
Clinical chemistry 1999;45(11):1960-6.
1999: Angeliki Magklara; Andreas Scorilas; C López-Otín; F Vizoso; A Ruibal; Eleftherios P Diamandis
Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid.
Clinical chemistry 1999;45(10):1774-80.
1999: Andreas Scorilas; Eleftherios P Diamandis; Michael A Levesque; A Papanastasiou-Diamandi; M Javad Khosravi; Maurizia Giai; Riccardo Ponzone; Riccardo Roagna; Piero Sismondi; C López-Otin
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1778-85.
1999: Andreas Scorilas; Julia Yotis; C Pateras; Theoni Trangas; Maroulio Talieri
Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):815-21.
1998: Andreas Scorilas; Nelly Courtis; Julia Yotis; Maroulio Talieri; M Michailakis; Theoni Trangas
Poly(A)polymerase activity levels in breast tumour cytosols.
Journal of experimental & clinical cancer research : CR 1998;17(4):511-8.
1998: Alexandros Ardavanis; Andreas Scorilas; A Loukeri; F Gerakini; Georgios Pissakas; Ioannis Missitzis; Nikiforos Apostolikas; I Yiotis
Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence.
Anticancer research 1998;18(4B):2885-90.
1997: Alexandros Ardavanis; F Gerakini; A Amanatidou; Andreas Scorilas; C Pateras; A Garoufali; Georgios Pissakas; K Stravolemos; Nikiforos Apostolikas; I Yiotis
Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance.
Anticancer research 1997;17(5A):3665-9.
1997: Alexandros Ardavanis; Andreas Scorilas; A Amanatidou; F Gerakini; Ioannis Missitzis; A Garoufali; Georgios Pissakas; C Pateras; Nikiforos Apostolikas; Gerasimos Rigatos; I Yiotis
Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer.
Anticancer research 1997;17(2B):1405-9.
1995: Andreas Scorilas; Julia Yotis; K Stravolemos; D Gouriotis; A Keramopoulos; K Ampela; Maroulio Talieri; Theoni Trangas
c-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients.
Anticancer research 1995;15(4):1543-7.
1993: Andreas Scorilas; Julia Yotis; D Gouriotis; A Keramopoulos; K Ampela; Theoni Trangas; Maroulio Talieri
Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
Anticancer research 1993;13(5C):1895-900.